Nina Patel, M.D.
Professor of Clinical Medicine
Associate Director of Interstitial Lung Disease Program
Dr. Patel is an Assistant Professor of Clinical Medicine at Columbia University. Dr. Patel completed her Internal Medicine residency and Pulmonary and Critical Care fellowship training at the University of Chicago. She is the Associate Director of Columbia University-New York Presbyterian Hospital’s Interstitial Lung Disease Program, and leads a multidisciplinary conference focused on the development of diagnostic and treatment plans for patients with interstitial lung disease. She is a principal or sub-investigator on a number of clinical trials exploring the efficacy of novel therapies in IPF, and has investigated the development of pulmonary hypertension in IPF. Dr. Patel is also a founding member of the Columbia Pulmonary Associates, a pulmonary practice group at Columbia University. Her clinical interests include interstitial lung disease, occupational lung disease, general pulmonary medicine and medical critical care.
Education and Training
- B.S. in Medical Science, Boston University, Boston, MA, 1992-1995
- Medical School:
- Boston University School of Medicine, Boston, MA, 1995-1999
- Internal Medicine, University of Chicago Hospitals, Chicago, IL, 2000-2002
- Pulmonary and Critical Care Medicine, University of Chicago Hospitals, Chicago, IL, 2002-2005
Selected Honors and Awards
- 07/2008-07/2012 Stony-World Herbert Fund, Grant in Aid
- 2002 Top 10 Best Teaching Residents, Internal Medicine Residency
- 1999 Boston University, Cum Laude
- 1996 Pathology Honors Society
Other Experience and Professional Membership
American Thoracic Society
American College of Chest Physicians
Columbia Pulmonary Associates
Herbert Irving Pavilion
161 Fort Washington Avenue, 310
New York, NY 10032
- Pulmonary Disease Medicine
- Critical Care Medicine
- General pulmonary disease
- Respiratory failure
- Acute respiratory distress syndrome
- Idiopathic pulmonary fibrosis
- Interstitial lung disease
- Internal Medicine Diplomate, 2002, 2012
- Pulmonary Disease Diplomate, 2005
- Critical Care Medicine Diplomate, 2006
- Novel Therapies for the treatment of Idiopathic Pulmonary Fibrosis
- Pulmonary Vascular Disease in Idiopathic Pulmonary Fibrosis
- Patel NM, Kawut SM, Jelic S, Arcasoy SM, Lederer DJ, Borczuk AC. Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis. Eur Respir J 2012 [Epub ahead of print]. PMID: 22997216
- McConville JF, Fernandes DJ, Churchill J, Dewundara S, Kogut P, Shah S, Fuchs G, Kedainis D, Bellam SK, Patel NM, McCauley J, Dulin NO, Gupta MP, Adam S, Yoneda Y, Camoretti-Mercado B, Solway J. Nuclear import of serum response factor in airway smooth muscle cells. Am J Respir Cell Mol Biol. 2011 Sep;45(3):453-8.
- J.T. Chen, M. L. Wilgus, M.D. Bacchetta, S. C. Jacoby, H. D. Brodie, N. Patel. A woman with severe ARDS secondary to Plasmodium vivax and ovale successfully bridged to recovery with venovenous extracorporeal membrane oxygenation (ECMO). Am J Respir Crit Care Med 2011;183: A5880.
- Patel NM, Lederer DJ, Borczuk AC, Kawut SM. Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 2007;132(3):998-1006.
- Patel NM, Pohlman A, Husain A, Noth I, Hall JB, Kress JP. Conventional transbronchial needle aspiration decreases the rate of surgical sampling of intrathoracic lymphadenopathy. Chest 2007;131(3):773-8.
- Nicolae D, Cox NJ, Lester LA, Schneider D, Tan Z, Billstrand C, Kuldanek S, Donfack J, Kogut P, Patel NM, Goodenbour J, Howard T, Wolf R, Koppelman GH, White SR, Parry R, Postma DS, Meyers D, Bleecker ER, Hunt JS, Solway J, Ober C. Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet. 2005 Feb;76(2):349-57.
- H. Poor, S.M. Arcasoy, S.M. Kawut, N. Philip, D. Rybak, M. Huang, N. Patel, L. Shah, J. Wilt, D.J. Lederer. Abs. ID/Title: #2643 - Elevated Plasma TGF-β1 Levels are Associated with Poor Outcomes in Idiopathic Pulmonary Fibrosis. 2010 ATS International Conference.
- C. Winterbottom, S.M. Arcasoy, N. Philip, D. Rybak, D. Shimbo, N. Patel, L. Shah, J. Wilt, D.J. Lederer. Abs. ID/Title: #2643 - Serum CA 15-3, a MUC1 Tumor Marker, Is Elevated in Idiopathic Pulmonary Fibrosis. 2010 ATS International Conference.
- A. Giunta, S.M. Arcasoy, N. Patel, J. Wilt, D.J. Lederer. Abs. ID/Title: #1556 - Low Socioeconomic Status is associated with Greater Disease Severity in Idiopathic Pulmonary Fibrosis. 2010 ATS International Conference.
- J. Hook, D. Zemmel, N. Philip, D. Rybak, M. Koeckert, L. Shah, M. Bartels, N. Patel, S.M. Arcasoy, D.J. Lederer. Abs. ID/Title: #580 - A Novel Point-of-Care Oxygen Titration Study to Predict Outcome in Interstitial Lung Disease. 2010 ATS International Conference.
- Patel NM, Kawut SM, Powell CA, Lederer DJ, Factor PH, Borczuk AC. Gene Expression Profiling of Pulmonary Hypertension (PH) in Idiopathic Pulmonary Fibrosis (IPF). 2008 ATS International Conference.
- Park S, Kawut SM, Simonelli, PF, Patel NM, Al-Naamani N, Rybak, D, Schluger NW, Arcasoy, SM., Lederer DJ. Socioeconomic Status and Disease Severity in Diffuse Parenchymal Lung Disease. 2008 ATS International Conference.
- Patel N.M. and Kogut P, Camoretti-Mercado B, McConville J, Churchill JD, Sperling A, White S, Ober C, Solway J. Transcriptional Regulation of Human Leukocyte Antigen-G (HLA-G) in Human Airway Epithelium. 2005 ATS International Conference.